Dietary analysis Participants were required to record their dietary intake for 4 consecutive days prior to each of the 3 testing sessions that occurred at prior to baseline and during weeks 4 and 8
Liraglutide: GLP-1 analog format used in comparative incretin studies
Additionally, prior authorizations for these medications will end on specific dates, necessitating new requests and potential disruptions in treatment
Bile Acids Trigger GLP-1 Release Predominantly by Activating GPBAR1 (TGR5) on the Basolateral L-Cell Membrane
When weight loss medications are included, plans may require clinical records, prior authorization, BMI verification, and medical necessity review
Summary: GLP-1 medications do not selectively burn belly fat but promote generalised weight loss that includes significant reductions in visceral abdominal fat